Remove the needle from the NovoLog FlexPen after each injection and dispose of it
The compound is still working through Eli Lilly's TRIUMPH Phase 3 program, with seven additional trial readouts expected through 2026 alongside the already-reported TRIUMPH-4 data from December 2025
J Biol Chem 267 , 2143221437 (1992)
PLAINSBORO, NJ, June 4, 2021 Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved the new drug application (NDA) for Wegovy (semaglutide) injection 2.4 mg, the first-and-only prescription weight-loss medication with once-weekly dosing
Peptides that are supplied in vials make it simple for researchers to regulate dosage measurements, guaranteeing precision
Lopes FHA, Freitas MVC, de Bruin VMS, de Bruin PFC